All Policy articles – Page 2
-
NewsIncrease in multidrug-resistant pathogens since Ukraine war
Researchers in Germany have recommended screening patients from Ukraine for multi-drug resistant pathogens prior to hospital admission following a series of outbreaks.
-
NewsRegulatory pathway needs to be developed to make the most of phages: AMI
A regulatory pathway needs to be developed if the UK is to reap the benefits of bacteriophage therapy, Applied Microbiology International (AMI) has warned. France, Belgium and Poland are already developing programmes that take advantage of the potential of phage therapeutics, while bacteriophages - viruses that are capable of destroying ...
-
NewsAMI putting together recommendations to support UK government action on AMR
Applied Microbiology International is putting together recommendations for the UK to deliver its five-year action plan on tackling antimicrobial resistance (AMR) in the run-up to 2030.
-
NewsSfAM changes name to Applied Microbiology International in major rebrand
The Society for Applied Microbiology (SfAM) has formally changed its name to Applied Microbiology International (AMI) in the latest evolutionary step for the organisation.
-
NewsAMI’s pitch on bacteriophages is winner of My Science Inquiry
Applied Microbiology International’s pitch to explore bacteriophages as an alternative to antimicrobial drugs has been selected by the Commons Science and Technology Committee as the winner of the My Science inquiry.
-
NewsWelcome to the launch of The Microbiologist
With a fresh new team who are enthused about communicating all things microbiology, our user-friendly online magazine will deliver the very latest news in microbiology, including exclusive content for Applied Microbiology International (AMI) members and daily updates on research and policy developments.
-
NewsAMI pitches Government to develop pathway to phage therapy
Applied Microbiology International is urging the UK Government to launch an inquiry to explore the regulatory barriers and opportunities for bacteriophage therapy in the UK, in order to explore their potential as an alternative or addition to conventional antimicrobial drugs.
- Previous Page
- Page1
- Page2
- Next Page
